• Home
  • >
  • Medicamen Biotech Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/medicamen-biotech-ltd.png Logo

Medicamen Biotech Ltd Financial Statement

Medicamen Biotech Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue45.0443.2240.88
Operating Expense38.6236.5233.09
Net Profit2.773.014.42
Net Profit Margin6.156.9610.81
Earning Per Share2.192.383.49
EBIDTA6.176.918.31
Effective Tax Rate15.4217.7616.05

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Medicamen Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual140.87115.45112.72
Operating Expenses Annual11791.993.49
Operating Profit Annual26.3325.2719.98
Interest Annual2.921.41.06
Depreciation6.265.672.45
Net Profit Annual14.8414.912.13
Tax Annual2.323.24.26

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Medicamen Biotech Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning3.823.893.09
Cash Flow from Operations-6.294.1112.77
Cash Flow from Investing-5.88-8.47-17.81
Cash Flow from Financing29.134.35.84
Cash Flow at the End20.783.823.89

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Medicamen Biotech Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)19.0222.3618.12
PBIT Margin (%)14.517.3615.88
PBT Margin (%)10.138.415.12
Net PROFIT Margin (%)10.8812.9111.34
Return On Networth / Equity (%)8.6710.679.55
Return On Networth /Employed(%)10.3612.2712.49
Return On Assets (%)7.729.178.96
Total Debt / Equity(X)0.150.160.12
Asset Turnover Ratio (%)0.710.710.79

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Medicamen Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual92.6692.4889.64
Total Current Assets Annual163.36123.0496.03
Non Current Assets Annual115.15102.6697.69
Total Shareholders Funds Annual193.41146.47132.89
Total Assets Annual278.52225.69193.72

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Medicamen Biotech Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Medicamen Biotech Ltd has a market capitalization of 829.34 Cr. Value Research classifies it as a Small-Cap company.

Yes, Medicamen Biotech Ltd is debt-free with a debt-to-equity ratio of 0.13.

In FY 2023, Medicamen Biotech Ltd recorded a total revenue of approximately 140.87 Cr marking a significant milestone in the company's financial performance.

Medicamen Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..

Medicamen Biotech Ltd's current PE ratio is 55.89.

Medicamen Biotech Ltd's ROCE averaged 10.7% from the FY ending March 2021 to 2023, with a median of 11.4%. It peaked at 11.6% in March 2021, reflecting strong capital efficiency over the period..

Medicamen Biotech Ltd's latest EBIT is Rs. 19.97 Cr, surpassing the average EBIT of Rs. 18.97 Cr over the 5 years..